©2025 Glaukos Corporation. All rights reserved.
Glaukos and iDose are registered trademarks of Glaukos Corporation.
All other trademarks are the property of their respective owners.
PM-US-2894
to schedule a glaucoma consultation at Harvard Eye Associates.
Call
OR
for a member of our team to contact you.
(949) 951-2020
Submit the form below
iDose TR is a convenient way to lower eye pressure for people with open-angle glaucoma or high eye pressure (ocular hypertension).
Barely visible to the human eye, iDose TR is a tiny implant specially designed to continuously release the prescription medication you need, when you need it.
See the difference with iDose TR
Learn more about the convenient way to lower eye pressure for people with open-angle glaucoma or high eye pressure (ocular hypertension).
What makes iDose TR unique?
iDose TR is an FDA-approved, all-in-one prescription medicine and drug delivery system for lowering eye pressure.
Helps you take control of your eye pressure without worrying if you put your medication in correctly and at the right time
FDA-approved safe and effective
Designed to help people with glaucoma take long-term control of high eye pressure
Proactively manages eye pressure earlier in the treatment journey, which may help slow the progression of glaucoma and minimize vision loss
Continuously delivers prescription medication without the challenges or inconvenience of a prescription eye drop—in clinical studies, 8 out of 10 people were free of prescription eye drops at 12 months with iDose TR
The safety and efficacy of iDose TR were proven in 2 large clinical studies of 1,150 people with high eye pressure
Provides continuous, 24/7 release of medication directly inside the eye to help lower eye pressure
Minimal side effects—in clinical studies, the most common side effects were reported in only 2-6% of people
The most common side effects of iDose TR were increased eye pressure, inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness, and reduced vision.
Dr. Savak Teymoorian is a board-certified ophthalmologist with advanced specialized training in glaucoma from Stanford University. Dr Teymoorian provides patients with a full range of eye care utilizing the newest advancements available, like iDose TR, to help those suffering from increased eye pressure.
Dr. Savak Teymoorian
Dr. Elaine Wang is a board-certified ophthalmologist and glaucoma fellow from the world-renowned Bascom Palmer Eye Institute. Dr. Wang has extensive experience in a variety of glaucoma treatment options, including iDose TR.
Dr. Elaine Wang
Innovative solutions for glaucoma management
IMPORTANT SAFETY INFORMATION
iDose TR may be covered by most insurance plans.
